CoChat

Autophagy has a key role in the pathophysiology of schizophrenia

Open access
Merenlender-Wagner, A, Malishkevich, A, Shemer, Z, Udawela, M, Gibbons, A, Scarr, E, Dean, B, Levine, J, Agam, G, Gozes, I · 2015 · Molecular Psychiatry
Cited by 241

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Autophagy is a process preserving the balance between synthesis, degradation and recycling of cellular components and is therefore essential for neuronal survival and function. Several key proteins govern the autophagy pathway including beclin1 and microtubule associated protein 1 light chain 3 (LC3). Here, we show a brain-specific reduction in beclin1 expression in postmortem hippocampus of schizophrenia patients, not detected in peripheral lymphocytes. This is in contrast with activity-dependent neuroprotective protein (ADNP) and ADNP2, which we have previously found to be deregulated in postmortem hippocampal samples from schizophrenia patients, but that now showed a significantly increased expression in lymphocytes from related patients, similar to increases in the anti-apoptotic, beclin1-interacting, Bcl2. The increase in ADNP was associated with the initial stages of the disease, possibly reflecting a compensatory effect. The increase in ADNP2 might be a consequence of neuroleptic treatment, as seen in rats subjected to clozapine treatment. ADNP haploinsufficiency in mice, which results in age-related neuronal death, cognitive and social dysfunction, exhibited reduced hippocampal beclin1 and increased Bcl2 expression (mimicking schizophrenia and normal human aging). At the protein level, ADNP co-immunoprecipitated with LC3B suggesting a direct association with the autophagy process and paving the path to novel targets for drug design.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2013.174

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 36

  1. Mortensen M, Ferguson DJ, Edelmann M, Kessler B, Morten KJ, Komatsu M et al. Loss of autophagy in erythroid cells leads to defective removal of mitochondria and severe anemia in vivo. Proc Natl Acad Sci USA 2010; 107: 832–837. · DOI · Paper page
  2. Debnath J, Baehrecke EH, Kroemer G . Does autophagy contribute to cell death? Autophagy 2005; 1: 66–74. · DOI · Paper page
  3. Lieberman JA . Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 1999; 46: 729–739. · DOI · Paper page
  4. Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF . Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 2006; 81: 47–63. · DOI · Paper page
  5. Sun Q, Fan W, Zhong Q . Regulation of Beclin 1 in autophagy. Autophagy 2009; 5: 713–716. · DOI · Paper page
  6. Wang J . Beclin 1 bridges autophagy, apoptosis and differentiation. Autophagy 2008; 4: 947–948. · DOI · Paper page
  7. Kim M, Fekadu J, Maronde E, Rami A . Alleviation of autophagy by knockdown of Beclin-1 enhances susceptibility of hippocampal neurons to proapoptotic signals induced by amino acid starvation. Histochem Cell Biol 2013; 139: 99–108. · DOI
  8. Homma K, Suzuki K, Sugawara H . The Autophagy Database: an all-inclusive information resource on autophagy that provides nourishment for research. Nucleic Acids Res 2011; 39: D986–D990. · DOI · Paper page
  9. Wu J, Dang Y, Su W, Liu C, Ma H, Shan Y et al. Molecular cloning and characterization of rat LC3A and LC3B—two novel markers of autophagosome. Biochem Biophys Res Commun 2006; 339: 437–442. · DOI · Paper page
  10. Mizushima N . Autophagy: process and function. Genes Dev 2007; 21: 2861–2873. · DOI · Paper page
  11. Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J et al. A directed protein interaction network for investigating intracellular signal transduction. Sci Signal 2011; 4: rs8. · DOI · Paper page
  12. Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, Perl O et al. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem 1999; 72: 1283–1293. · DOI · Paper page
  13. Kushnir M, Dresner E, Mandel S, Gozes I . Silencing of the ADNP-family member, ADNP2, results in changes in cellular viability under oxidative stress. J Neurochem 2008; 105: 537–545. · DOI
  14. Sigalov E, Fridkin M, Brenneman DE, Gozes I . VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury. J Mol Neurosci 2000; 15: 147–154. · DOI
  15. Pinhasov A, Mandel S, Torchinsky A, Giladi E, Pittel Z, Goldsweig AM et al. Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res Dev Brain Res 2003; 144: 83–90. · DOI · Paper page
  16. Furman S, Steingart RA, Mandel S, Hauser JM, Brenneman DE, Gozes I . Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. Neuron Glia Biol 2004; 1: 193–199. · DOI · Paper page
  17. Steingart RA, Gozes I . Recombinant activity-dependent neuroprotective protein protects cells against oxidative stress. Mol Cell Endocrinol 2006; 252: 148–153. · DOI
  18. Divinski I, Mittelman L, Gozes I . A femtomolar acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication. J Biol Chem 2004; 279: 28531–28538. · DOI · Paper page
  19. Khandhadia S, Cherry J, Lotety AJ . Age-Related Macular Degeneration. Neurodegener Diseases In: Ahmad SI, Landes Bioscience + Business Media (eds). 2012; Chapter 2, pp15–36.
  20. Gozes I, Steingart RA, Spier AD . NAP mechanisms of neuroprotection. J Mol Neurosci 2004; 24: pp67–72. · DOI
  21. Leker RR, Teichner A, Grigoriadis N, Ovadia H, Brenneman DE, Fridkin M et al. NAP, a femtomolar-acting peptide, protects the brain against ischemic injury by reducing apoptotic death. Stroke 2002; 33: 1085–1092. · DOI · Paper page
  22. Idan-Feldman A, Ostritsky R, Gozes I . Tau and caspase 3 as targets for neuroprotection. Int J Alzheimers Dis 2012; 2012: 493670.
  23. Idan-Feldman A, Schirer Y, Polyzoidou E, Touloumi O, Lagoudaki R, Grigoriadis NC et al. Davunetide (NAP) as a preventative treatment for central nervous system complications in a diabetes rat model. Neurobiol Dis 2011; 44: 327–339. · DOI
  24. Zemlyak I, Sapolsky R, Gozes I . NAP protects against cytochrome c release: inhibition of the initiation of apoptosis. Eur J Pharmacol 2009; 618: 9–14. · DOI
  25. Zemlyak I, Manley N, Sapolsky R, Gozes I . NAP protects hippocampal neurons against multiple toxins. Peptides 2007; 28: 2004–2008. · DOI
  26. Dresner E, Agam G, Gozes I . Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia. Eur Neuropsychopharmacol 2011; 21: 355–361. · DOI
  27. Merenlender-Wagner A, Pikman R, Giladi E, Andrieux A, Gozes I . NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse—a microtubule-deficient model of schizophrenia. Peptides 2010; 31: 1368–1373. · DOI
  28. Javitt DC, Buchanan RW, Keefe RS, Kern R, McMahon RP, Green MF et al. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res 2012; 136: 25–31. · DOI
  29. Jarskog LF, Dong Z, Kangarlu A, Colibazzi T, Girgis RR, Kegeles LS et al. Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology 2013; 38: 1245–1252. · DOI
  30. Erlich S, Mizrachy L, Segev O, Lindenboim L, Zmira O, Adi-Harel S et al. Differential interactions between Beclin 1 and Bcl-2 family members. Autophagy 2007; 3: 561–568. · DOI · Paper page
  31. Kozlovsky N, Nadri C, Belmaker RH, Agam G . Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activity. Int J Neuropsychopharmacol 2003; 6: 117–120. · DOI
  32. Zink M, Schmitt A, May B, Muller B, Demirakca T, Braus DF et al. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression. Schizophr Res 2004; 66: 151–157. · DOI
  33. Dresner E, Agam G, Gozes I . Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: Deregulation in schizophrenia. Eur Neuropsychopharmacol 2011; 21: 355–361. · DOI
  34. Furman S, Hill JM, Vulih I, Zaltzman R, Hauser JM, Brenneman DE et al. Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus. Neurosci Lett 2005; 373: 73–78. · DOI
  35. Begemann MJ, Dekker CF, van Lunenburg M, Sommer IE . Estrogen augmentation in schizophrenia: a quantitative review of current evidence. Schizophr Res 2012; 141: 179–184. · DOI
  36. Esteves AR, Gozes I, Cardoso SM . The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease. Biochim Biophys Acta 2013; 1842: 7–21. · DOI

Cited by

See all 241

Metadata

Authors
Merenlender-Wagner, A., Malishkevich, A., Shemer, Z., Udawela, M., Gibbons, A., Scarr, E., Dean, B., Levine, J., Agam, G., & Gozes, I.
Venue
Molecular Psychiatry
Published
2013-12-24
Volume
20
Issue
1
Pages
126-132
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2030430356
Cited by
241
References
14
FWCI
8.43
Type
journal article
Language
en
Open access
hybrid
Licence
creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Autophagy has a key role in the pathophysiology of schizophrenia. https://app.cochat.ai/papers/10.1038/mp.2013.174
The paper
Merenlender-Wagner, A., Malishkevich, A., Shemer, Z., Udawela, M., Gibbons, A., Scarr, E., Dean, B., Levine, J., Agam, G., & Gozes, I. (2015). Autophagy has a key role in the pathophysiology of schizophrenia. Molecular Psychiatry. https://doi.org/10.1038/mp.2013.174

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.